Abstract
Mounting evidence indicates that the female sex is a risk factor for Alzheimer’s disease (AD), the most common cause of dementia worldwide. Decades of research suggest that sex-specific differences in genetics, environmental factors, hormones, comorbidities, and brain structure and function may contribute to AD development. However, although significant progress has been made in uncovering specific genetic factors and biological pathways, the precise mechanisms underlying sex-biased differences are not fully characterized. Here, we review several lines of evidence, including epidemiological, clinical, and molecular studies addressing sex differences in AD. In addition, we discuss the challenges and future directions in advancing personalized treatments for AD.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal NT, Bienias JL, Bennett DA, Wilson RS, Morris MC, Schneider JA, Shah RC, Evans DA (2006) The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology 26:140–146. https://doi.org/10.1159/000091654
Anastas'eva NV, Pasman NM, Soboleva MK, Loseva MI (1985) Morphological and functional characteristics of erythrocytes of mothers with late pregnancy toxemias and their newborn infants. Akush Ginekol (Mosk):18–21
Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C et al (1999) Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM Incidence Research Group. Neurology 53:1992–1997. https://doi.org/10.1212/wnl.53.9.1992
Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, van der Flier WM, Sikkes SAM, Teunissen CE (2020) Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE epsilon4 genotype. Neurology 95:e2378–e2388. https://doi.org/10.1212/WNL.0000000000010629
Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D'Agostino RB (1993) Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham study. Neurology 43:515–519. https://doi.org/10.1212/wnl.43.3_part_1.515
Barford A, Dorling D, Davey Smith G, Shaw M (2006) Life expectancy: women now on top everywhere. BMJ 332:808. https://doi.org/10.1136/bmj.332.7545.808
Benedict C, Kern W, Schultes B, Born J, Hallschmid M (2008) Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab 93:1339–1344. https://doi.org/10.1210/jc.2007-2606
Bi Q, Zhou X, Lu Y, Fu W, Wang Y, Wang F, Wang J (2022) Polymorphisms of the apolipoprotein E gene affect response to atorvastatin therapy in acute ischemic stroke. Front Cardiovasc Med 9:1024014. https://doi.org/10.3389/fcvm.2022.1024014
Bouter C, Vogelgsang J, Wiltfang J (2019) Comparison between amyloid-PET and CSF amyloid-beta biomarkers in a clinical cohort with memory deficits. Clin Chim Acta 492:62–68. https://doi.org/10.1016/j.cca.2019.02.005
Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–278.; discussion 278–284. https://doi.org/10.1016/0197-4580(95)00021-6
Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, the NFL Group, Alvarez-Cermeno JC, Andreasson U, Axelsson M, Backstrom DC et al (2019) Diagnostic value of cerebrospinal fluid Neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76:1035–1048. https://doi.org/10.1001/jamaneurol.2019.1534
Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ et al (2018) Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer's disease: findings from three well-characterized cohorts. Alzheimers Dement 14:1193–1203. https://doi.org/10.1016/j.jalz.2018.04.010
Buckley RF, Mormino EC, Chhatwal J, Schultz AP, Rabin JS, Rentz DM, Acar D, Properzi MJ, Dumurgier J, Jacobs H et al (2019) Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid. Neurobiol Aging 78:178–185. https://doi.org/10.1016/j.neurobiolaging.2019.02.019
Buckley RF, O'Donnell A, McGrath ER, Jacobs HIL, Lois C, Satizabal CL, Ghosh S, Rubinstein ZB, Murabito JM, Sperling RA et al (2022) Menopause status moderates sex differences in tau burden: a Framingham PET study. Ann Neurol 92:11–22. https://doi.org/10.1002/ana.26382
Burke SL, Hu T, Fava NM, Li T, Rodriguez MJ, Schuldiner KL, Burgess A, Laird A (2019) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging 31:140–164. https://doi.org/10.1080/08952841.2018.1419476
Carretero J, Sanchez-Robledo V, Carretero-Hernandez M, Catalano-Iniesta L, Garcia-Barrado MJ, Iglesias-Osma MC, Blanco EJ (2019) Prolactin system in the hippocampus. Cell Tissue Res 375:193–199. https://doi.org/10.1007/s00441-018-2858-2
Cavedo E, Chiesa PA, Houot M, Ferretti MT, Grothe MJ, Teipel SJ, Lista S, Habert MO, Potier MC, Dubois B et al (2018) Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints. Alzheimers Dement 14:1204–1215. https://doi.org/10.1016/j.jalz.2018.05.014
Chapman RM, Mapstone M, Gardner MN, Sandoval TC, McCrary JW, Guillily MD, Reilly LA, DeGrush E (2011) Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women. J Int Neuropsychol Soc 17:654–662. https://doi.org/10.1017/S1355617711000452
Chatterjee S, Mudher A (2018) Alzheimer's disease and type 2 diabetes: a critical assessment of the shared pathological traits. Front Neurosci 12:383. https://doi.org/10.3389/fnins.2018.00383
Clegg DJ, Brown LM, Woods SC, Benoit SC (2006) Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 55:978–987. https://doi.org/10.2337/diabetes.55.04.06.db05-1339
Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24–28. https://doi.org/10.1196/annals.1297.005
Costanza M, Pedotti R (2016) Prolactin: friend or foe in central nervous system autoimmune inflammation? Int J Mol Sci 17. https://doi.org/10.3390/ijms17122026
Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR et al (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69:29–38. https://doi.org/10.1001/archneurol.2011.233
Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ et al (2017) Effects of regular and long-acting insulin on cognition and Alzheimer's disease biomarkers: a pilot clinical trial. J Alzheimers Dis 57:1325–1334. https://doi.org/10.3233/JAD-161256
Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K et al (2020) Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial. JAMA Neurol 77:1099–1109. https://doi.org/10.1001/jamaneurol.2020.1840
Davis EJ, Broestl L, Abdulai-Saiku S, Worden K, Bonham LW, Minones-Moyano E, Moreno AJ, Wang D, Chang K, Williams G et al (2020) A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease. Sci Transl Med 12. https://doi.org/10.1126/scitranslmed.aaz5677
Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G et al (2002) Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA study. J Am Geriatr Soc 50:41–48. https://doi.org/10.1046/j.1532-5415.2002.50006.x
El-Ganainy SO, Soliman OA, Ghazy AA, Allam M, Elbahnasi AI, Mansour AM, Gowayed MA (2022) Intranasal oxytocin attenuates cognitive impairment, beta-amyloid burden and tau deposition in female rats with Alzheimer's disease: interplay of ERK1/2/GSK3beta/Caspase-3. Neurochem Res. https://doi.org/10.1007/s11064-022-03624-x
Fan CC, Banks SJ, Thompson WK, Chen CH, McEvoy LK, Tan CH, Kukull W, Bennett DA, Farrer LA, Mayeux R et al (2020) Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. Brain 143:2272–2280. https://doi.org/10.1093/brain/awaa164
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278:1349–1356
Feld GB, Wilhem I, Benedict C, Rudel B, Klameth C, Born J, Hallschmid M (2016) Central nervous insulin signaling in sleep-associated memory formation and neuroendocrine regulation. Neuropsychopharmacology 41:1540–1550. https://doi.org/10.1038/npp.2015.312
Fisher DW, Bennett DA, Dong H (2018) Sexual dimorphism in predisposition to Alzheimer's disease. Neurobiol Aging 70:308–324. https://doi.org/10.1016/j.neurobiolaging.2018.04.004
Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B (1997) Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen project, Stockholm. Neurology 48:132–138. https://doi.org/10.1212/wnl.48.1.132
Gale SD, Baxter L, Thompson J (2016) Greater memory impairment in dementing females than males relative to sex-matched healthy controls. J Clin Exp Neuropsychol 38:527–533. https://doi.org/10.1080/13803395.2015.1132298
Ganguli M, Dodge HH, Chen P, Belle S, DeKosky ST (2000) Ten-year incidence of dementia in a rural elderly US community population: the MoVIES project. Neurology 54:1109–1116. https://doi.org/10.1212/wnl.54.5.1109
Garcia-Argibay M, Hiyoshi A, Fall K, Montgomery S (2022) Association of 5alpha-reductase inhibitors with dementia, depression, and suicide. JAMA Netw Open 5:e2248135. https://doi.org/10.1001/jamanetworkopen.2022.48135
Guerreiro R, Bras J (2015) The age factor in Alzheimer's disease. Genome Med 7:106. https://doi.org/10.1186/s13073-015-0232-5
Hall MJ (1986) Cassava toxicity. Lancet 1:95. https://doi.org/10.1016/s0140-6736(86)90742-7
Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA (2001) Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 153:132–136. https://doi.org/10.1093/aje/153.2.132
Irvine K, Laws KR, Gale TM, Kondel TK (2012) Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis. J Clin Exp Neuropsychol 34:989–998. https://doi.org/10.1080/13803395.2012.712676
Kamal H, Tan GC, Ibrahim SF, Shaikh MF, Mohamed IN, Mohamed RMP, Hamid AA, Ugusman A, Kumar J (2020) Alcohol use disorder, neurodegeneration, Alzheimer's and Parkinson's disease: interplay between oxidative stress, neuroimmune response and excitotoxicity. Front Cell Neurosci 14:282. https://doi.org/10.3389/fncel.2020.00282
Kautzky-Willer A, Harreiter J, Pacini G (2016) Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 37:278–316. https://doi.org/10.1210/er.2015-1137
Lei Y, Renyuan Z (2018) Effects of androgens on the amyloid-beta protein in Alzheimer's disease. Endocrinology 159:3885–3894. https://doi.org/10.1210/en.2018-00660
Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF (1999) Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 66:177–183. https://doi.org/10.1136/jnnp.66.2.177
Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM, Alzheimer's Disease Neuroimaging Initiative (2015) Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement (N Y) 1:103–110. https://doi.org/10.1016/j.trci.2015.07.001
Liu CK, Lai CL, Tai CT, Lin RT, Yen YY, Howng SL (1998) Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology 50:1572–1579. https://doi.org/10.1212/wnl.50.6.1572
Luine VN (2014) Estradiol and cognitive function: past, present and future. Horm Behav 66:602–618. https://doi.org/10.1016/j.yhbeh.2014.08.011
Mao L, Wang L, Bennett S, Xu J, Zou J (2022) Effects of follicle-stimulating hormone on fat metabolism and cognitive impairment in women during menopause. Front Physiol 13:1043237. https://doi.org/10.3389/fphys.2022.1043237
Marseglia A, Fratiglioni L, Kalpouzos G, Wang R, Backman L, Xu W (2019) Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: a population-based cohort study. Alzheimers Dement 15:25–33. https://doi.org/10.1016/j.jalz.2018.06.3060
Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL (2015) Alzheimer's disease. Nat Rev Dis Primers 1:15056. https://doi.org/10.1038/nrdp.2015.56
Matyi JM, Rattinger GB, Schwartz S, Buhusi M, Tschanz JT (2019) Lifetime estrogen exposure and cognition in late life: the Cache County study. Menopause 26:1366–1374. https://doi.org/10.1097/GME.0000000000001405
Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Vemuri P, Machulda MM, Graff-Radford J, Knopman DS, Jack CR Jr et al (2019) Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin. Alzheimers Dement 15:1437–1447. https://doi.org/10.1016/j.jalz.2019.07.009
Mielke MM, Aggarwal NT, Vila-Castelar C, Agarwal P, Arenaza-Urquijo EM, Brett B, Brugulat-Serrat A, DuBose LE, Eikelboom WS, Flatt J et al (2022) Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective. Alzheimers Dement. https://doi.org/10.1002/alz.12662
Mittendorfer B (2005) Insulin resistance: sex matters. Curr Opin Clin Nutr Metab Care 8:367–372. https://doi.org/10.1097/01.mco.0000172574.64019.98
Moreno-Gonzalez I, Estrada LD, Sanchez-Mejias E, Soto C (2013) Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease. Nat Commun 4:1495. https://doi.org/10.1038/ncomms2494
Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang LS, Romero K, Arneric SP, Redolfi A et al (2017) Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA Neurol 74:1178–1189. https://doi.org/10.1001/jamaneurol.2017.2188
Nordstrom A, Hadrevi J, Olsson T, Franks PW, Nordstrom P (2016) Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab 101:3740–3746. https://doi.org/10.1210/jc.2016-1915
Orsini CA, Brown TE, Hodges TE, Alonso-Caraballo Y, Winstanley CA, Becker JB (2022) Neural mechanisms mediating sex differences in motivation for reward: cognitive bias, food, gambling, and drugs of abuse. J Neurosci 42:8477–8487. https://doi.org/10.1523/JNEUROSCI.1378-22.2022
Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A (1998) Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147:574–580. https://doi.org/10.1093/oxfordjournals.aje.a009489
Qiu T, Xie F, Zeng Q, Shen Z, Du G, Xu X, Wang C, Li X, Luo X, Li K et al (2022) Interactions between cigarette smoking and cognitive status on functional connectivity of the cortico-striatal circuits in individuals without dementia: a resting-state functional MRI study. CNS Neurosci Ther 28:1195–1204. https://doi.org/10.1111/cns.13852
Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (2021) Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060). Alzheimers Dement 17:1966–1975. https://doi.org/10.1002/alz.12362
Rempe RG, Hartz AMS, Bauer B (2016) Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab 36:1481–1507. https://doi.org/10.1177/0271678X16655551
Rocca WA, Cha RH, Waring SC, Kokmen E (1998) Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol 148:51–62. https://doi.org/10.1093/oxfordjournals.aje.a009560
Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ (2006) Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci 26:13384–13389. https://doi.org/10.1523/JNEUROSCI.2514-06.2006
Rosario ER, Carroll J, Pike CJ (2010) Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res 1359:281–290. https://doi.org/10.1016/j.brainres.2010.08.068
Rosenbloom M, Barclay TR, Kashyap B, Hage L, O'Keefe LR, Svitak A, Pyle M, Frey W, Hanson LR (2021) A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal Glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease. Drugs Aging 38:407–415. https://doi.org/10.1007/s40266-021-00845-7
Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM (2001) Incidence of dementia: does gender make a difference? Neurobiol Aging 22:575–580. https://doi.org/10.1016/s0197-4580(01)00231-7
Santiago JA, Potashkin JA (2013a) Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends Mol Med 19:176–186. https://doi.org/10.1016/j.molmed.2013.01.002
Santiago JA, Potashkin JA (2013b) Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes. PloS One 8:e83940. https://doi.org/10.1371/journal.pone.0083940
Santiago JA, Potashkin JA (2014) System-based approaches to decode the molecular links in Parkinson's disease and diabetes. Neurobiol Dis 72(Pt A):84–91. https://doi.org/10.1016/j.nbd.2014.03.019
Santiago JA, Potashkin JA (2015a) Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease. Proc Natl Acad Sci U S A 112:2257–2262. https://doi.org/10.1073/pnas.1423573112
Santiago JA, Potashkin JA (2015b) Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson's disease patients. PloS One 10:e0142582. https://doi.org/10.1371/journal.pone.0142582
Santiago JA, Potashkin JA (2021) The impact of disease comorbidities in Alzheimer's disease. Front Aging Neurosci 13:631770. https://doi.org/10.3389/fnagi.2021.631770
Santiago JA, Bottero V, Potashkin JA (2019) Transcriptomic and network analysis highlight the association of diabetes at different stages of Alzheimer's disease. Front Neurosci 13:1273. https://doi.org/10.3389/fnins.2019.01273
Santiago JA, Quinn JP, Potashkin JA (2022) Sex-specific transcriptional rewiring in the brain of Alzheimer's disease patients. Front Aging Neurosci 14:1009368. https://doi.org/10.3389/fnagi.2022.1009368
Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P (2004) Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology 62:1580–1584. https://doi.org/10.1212/01.wnl.0000123249.58898.e0
Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE et al (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women's health initiative memory study. JAMA 291:2947–2958. https://doi.org/10.1001/jama.291.24.2947
Skup M, Zhu H, Wang Y, Giovanello KS, Lin JA, Shen D, Shi F, Gao W, Lin W, Fan Y et al (2011) Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI. Neuroimage 56:890–906. https://doi.org/10.1016/j.neuroimage.2011.02.060
Tarawneh R, D'Angelo G, Crimmins D, Herries E, Griest T, Fagan AM, Zipfel GJ, Ladenson JH, Morris JC, Holtzman DM (2016) Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease. JAMA Neurol 73:561–571. https://doi.org/10.1001/jamaneurol.2016.0086
Tsiknia AA, Sundermann EE, Reas ET, Edland SD, Brewer JB, Galasko D, Banks SJ, Alzheimer's Disease Neuroimaging Initiative (2022) Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity. Alzheimers Res Ther 14:160. https://doi.org/10.1186/s13195-022-01106-4
Wang X, Wang C, Geng C, Zhao K (2018) LncRNA XIST knockdown attenuates Abeta(25-35)-induced toxicity, oxidative stress, and apoptosis in primary cultured rat hippocampal neurons by targeting miR-132. Int J Clin Exp Pathol 11:3915–3924
Wang X, Broce I, Deters KD, Fan CC, Banks SJ (2022) Identification of sex-specific genetic variants associated with Tau PET. Neurol Genet 8:e200043. https://doi.org/10.1212/NXG.0000000000200043
Warnich L, Drogemoller BI, Pepper MS, Dandara C, Wright GE (2011) Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation. Curr Pharmacogenomics Person Med 9:191–207. https://doi.org/10.2174/187569211796957575
Williamson J, Yabluchanskiy A, Mukli P, Wu DH, Sonntag W, Ciro C, Yang Y (2022) Sex differences in brain functional connectivity of hippocampus in mild cognitive impairment. Front Aging Neurosci 14:959394. https://doi.org/10.3389/fnagi.2022.959394
Xiong J, Kang SS, Wang Z, Liu X, Kuo TC, Korkmaz F, Padilla A, Miyashita S, Chan P, Zhang Z et al (2022) FSH blockade improves cognition in mice with Alzheimer's disease. Nature 603:470–476. https://doi.org/10.1038/s41586-022-04463-0
Yan S, Zheng C, Paranjpe MD, Li Y, Li W, Wang X, Benzinger TLS, Lu J, Zhou Y (2021) Sex modifies APOE epsilon4 dose effect on brain tau deposition in cognitively impaired individuals. Brain 144:3201–3211. https://doi.org/10.1093/brain/awab160
Yang JJ, Keohane LM, Pan X, Qu R, Shu XO, Lipworth LP, Braun K, Steinwandel MD, Dai Q, Shrubsole M et al (2022) Association of Healthy Lifestyles with risk of Alzheimer disease and related dementias in low-income black and White Americans. Neurology. https://doi.org/10.1212/WNL.0000000000200774
Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K et al (1995) Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology 45:1161–1168. https://doi.org/10.1212/wnl.45.6.1161
Zamani MR, Allen YS, Owen GP, Gray JA (1997) Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35) in hippocampal cultures. Neuroreport 8:513–517. https://doi.org/10.1097/00001756-199701200-00027
Zhornitsky S, Chaudhary S, Le TM, Chen Y, Zhang S, Potvin S, Chao HH, van Dyck CH, Li CR (2021) Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis. Psychiatry Res Neuroimaging 317:111380. https://doi.org/10.1016/j.pscychresns.2021.111380
Zissimopoulos JM, Barthold D, Brinton RD, Joyce G (2017) Sex and race differences in the association between statin use and the incidence of Alzheimer disease. JAMA Neurol 74:225–232. https://doi.org/10.1001/jamaneurol.2016.3783
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Santiago, J.A., Potashkin, J.A. (2023). Biological and Clinical Implications of Sex-Specific Differences in Alzheimer’s Disease. In: Tsirka, S.E., Acosta-Martinez, M. (eds) Sex and Gender Effects in Pharmacology . Handbook of Experimental Pharmacology, vol 282. Springer, Cham. https://doi.org/10.1007/164_2023_672
Download citation
DOI: https://doi.org/10.1007/164_2023_672
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-42647-6
Online ISBN: 978-3-031-42648-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)